Skip to main content

Clinical Pharmacology

6
Pipeline Programs
4
Companies
8
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
6
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Bayer
BayerLEVERKUSEN, Germany
4 programs
4
Fosrenol ODTPhase 11 trial
Loratadine + Pseudoephedrine sulfatePhase 11 trial
Loratadine + Pseudoephedrine sulfatePhase 11 trial
Nifedipine gastrointestinal therapeutic systemPhase 11 trial
Active Trials
NCT03074058Completed20Est. Aug 2015
NCT03517943Completed29Est. Aug 2018
NCT03517930Completed52Est. Jul 2018
+1 more trials
Lupeng Pharmaceutical
Lupeng PharmaceuticalChina - Guangzhou
2 programs
2
Rocbrutinib tabletsPhase 11 trial
[14C]LP-168Phase 11 trial
Active Trials
NCT07374224Recruiting28Est. Aug 2026
NCT06126861Completed6Est. Mar 2024
Cardurion Pharmaceuticals
1 program
CRD-740PHASE_11 trial
Active Trials
NCT05437094Completed20Est. Aug 2022
Takeda
TakedaTOKYO, Japan
1 program
SYR-322-METPHASE_31 trial
Active Trials
NCT02276274Completed12Est. Jun 2014

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
TakedaSYR-322-MET
Lupeng PharmaceuticalRocbrutinib tablets
Lupeng Pharmaceutical[14C]LP-168
Cardurion PharmaceuticalsCRD-740
BayerLoratadine + Pseudoephedrine sulfate
BayerLoratadine + Pseudoephedrine sulfate
BayerFosrenol ODT
BayerNifedipine gastrointestinal therapeutic system

Clinical Trials (8)

Total enrollment: 179 patients across 8 trials

Effect of Food on the Pharmacokinetics of Single Oral Dose Administration of a Fixed-Dose Combination of SYR-322 and Metformin Hydrochloride in Healthy Adult Male Subjects

Start: Jun 2014Est. completion: Jun 201412 patients
Phase 3Completed

A Study Evaluating the Effects of Itraconazole or Rifampin on the Pharmacokinetic Characteristics of Rocbrutinib Tablet

Start: Mar 2026Est. completion: Aug 202628 patients
Phase 1Recruiting

The Mass Balance Study of LP-168 in Healthy Subjects

Start: Dec 2023Est. completion: Mar 20246 patients
Phase 1Completed

Effect of Coadministration of Itraconazole on the Pharmacokinetics of CRD-740

Start: Jun 2022Est. completion: Aug 202220 patients
Phase 1Completed
NCT03517943BayerLoratadine + Pseudoephedrine sulfate

A Manufacturing Transfer Study Comparing the Bioequivalence of a Single Oral Dose of Claritin-D 12-Hour Extended Release Tablet From 2 Different Manufactuers Under Fed Conditions in Healthy Adult Subjects

Start: Apr 2018Est. completion: Aug 201829 patients
Phase 1Completed
NCT03517930BayerLoratadine + Pseudoephedrine sulfate

A Manufacturing Transfer Study Comparing the Bioequivalence of a Single Oral Dose of Claritin-D 12-Hour Extended Release Tablet From 2 Different Manufacturers Under Fasted Conditions in Healthy Adult Subjects

Start: Apr 2018Est. completion: Jul 201852 patients
Phase 1Completed
NCT03074058BayerFosrenol ODT

Bioequivalence Study of BAY 77-1931 Orally Disintegrating Tablet

Start: Jun 2015Est. completion: Aug 201520 patients
Phase 1Completed
NCT03136666BayerNifedipine gastrointestinal therapeutic system

Single Dose Escalation Study to Investigate the Pharmacokinetics as Well as Safety and Tolerability of a Concomitant Administration of Nifedipne GITS and Candesartan Tablets Under Fasting Conditions in Healthy Male Subjects in an Open Label, Non-randomized, Sequential Design.

Start: Apr 2010Est. completion: Jun 201012 patients
Phase 1Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 179 patients
4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.